Atenolol
Who holds supplier records for Atenolol? 6 organisations hold a current record for Atenolol: an active US FDA Type II Drug Master File or a CEP. A further 23 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), Italy (1) and Netherlands (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Atenolol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/atenolol
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
4 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Atenolol. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 7821, 15037 · latest filing Sept 2000
- KOPRAN RESEARCH LABORATORIES LTDIndiaCEPActive DMF 33007 · latest filing Jul 2018
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 14210 · latest filing Jun 1999
- SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRLItaly Company GMP cert on recordActive DMF 6979 · latest filing May 1987
- TAPI NL BVNetherlandsActive DMF 6213 · latest filing Mar 1986
- UNIQUE CHEMICALSIndiaActive DMF 24024 · latest filing Aug 2010
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Atenolol, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| KOPRAN RESEARCH LABORATORIES LIMITED Mumbai | IN | CEP 1998-017 - Rev 08 Atenolol | Jul 2025 | — |
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 1998-024 - Rev 06 Atenolol | Nov 2023 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | R1-CEP 2004-169 - Rev 04 Atenolol | Jul 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (23)
Organisations whose Type II DMFs for Atenolol are no longer active. These show a past filing, not current supply.
Show all 23 historical records
- AMRI INDIA PVT LTDInactive DMF 29971, 21659 · filed Nov 2015
- India · Inactive DMF 25010 · filed May 2011
- China · Inactive DMF 23327 · filed Dec 2009
- Taiwan · Inactive DMF 21617 · filed May 2008
- MYLAN LABORATORIES LTDInactive DMF 20399 · filed Apr 2007
- India · Inactive DMF 20268 · filed Feb 2007
- India · Inactive DMF 19672 · filed Jul 2006
- TIANJIN CENTRAL PHARMACEUTICAL CO LTDInactive DMF 17868 · filed Dec 2004
- SYNCHEM CHEMICALS PRIVATE LTDInactive DMF 11134 · filed Oct 1994
- PERIMMUNE INCInactive DMF 9196 · filed Jun 1991
- Italy · Inactive DMF 8965 · filed Feb 1991
- Italy · Inactive DMF 8834 · filed Oct 1990
- SHANGHAI NO 2 PHARMACEUTICAL FACTORYInactive DMF 8598 · filed Jun 1990
- FREEDOM CHEMICAL DIAMALT GMBHInactive DMF 8015 · filed Mar 1989
- Italy · Inactive DMF 7933 · filed Feb 1989
- FRANCIS SPAInactive DMF 7591 · filed Jul 1988
- SINTENOVA SAInactive DMF 7586 · filed Jul 1988
- AMSA ANONIMA MEDICINALI SINTETICI AND AFFINI SPAInactive DMF 7265 · filed Dec 1987
- PRODESFARMA QUIMICA SLInactive DMF 7175 · filed Oct 1987
- BLASCHIM SPAInactive DMF 7133 · filed Sept 1987
- USA · Inactive DMF 7101, 6905 · filed Aug 1987
- SIBEFAT SPAInactive DMF 6921 · filed Apr 1987
- Italy · Inactive DMF 6325 · filed Mar 1986
Overview
Atenolol is a cardioselective beta-blocker used in the treatment of hypertension and angina pectoris. It works by blocking the effects of adrenaline on the heart and blood vessels, thereby reducing heart rate and blood pressure.
Chemical identity
- IUPAC name
- 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide
- Canonical SMILES
- CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
- InChIKey
- METKIMKYRPQLGS-UHFFFAOYSA-N
- Synonyms
- Tenormin API, atenolol, Tenormin, Prenormine, Myocord, Duraatenolol, Betacard, Blokium, Corotenol, Normiten, Atehexal, Betablok
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- beta-Adrenergic Blocker
- Mechanism of action
- Adrenergic beta-Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Atenolol?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Atenolol: Ipca Laboratories Limited (India), KOPRAN RESEARCH LABORATORIES LTD (India), Zydus Lifesciences Limited (India), SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL (Italy), TAPI NL BV (Netherlands) and UNIQUE CHEMICALS (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Atenolol Drug Master Files are active?
Ipca Laboratories Limited (DMF 7821, 15037), KOPRAN RESEARCH LABORATORIES LTD (DMF 33007), Zydus Lifesciences Limited (DMF 14210), SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL (DMF 6979), TAPI NL BV (DMF 6213) and UNIQUE CHEMICALS (DMF 24024). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Atenolol records mean?
23 organisations have only inactive Type II DMFs for Atenolol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Atenolol have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Atenolol on the EDQM register, including KOPRAN RESEARCH LABORATORIES LIMITED Mumbai (IN), IPCA LABORATORIES LIMITED Mumbai (IN) and ZYDUS LIFESCIENCES LIMITED Vadodara (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Atenolol supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Atenolol?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.